Literature DB >> 18718257

Newborn screening for cystic fibrosis: a lesson in public health disparities.

Lainie Friedman Ross1.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18718257      PMCID： PMC2569148          DOI： 10.1016/j.jpeds.2008.04.061

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  69 in total

1.  False-negative primary neonatal thyroid screening: the need for clinical vigilance and secondary screening.

Authors:  K A Yunis; M R Nasr; G Lepejian; S Najjar; R Daher
Journal:  J Med Screen       Date:  2003       Impact factor: 2.136

2.  Ethical issues in cystic fibrosis newborn screening: from data to public health policy.

Authors:  Benjamin Wilfond; L S Rothenberg
Journal:  Curr Opin Pulm Med       Date:  2002-11       Impact factor: 3.155

3.  Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program.

Authors:  Don S Lee; Marjorie A Rosenberg; Andrew Peterson; Linda Makholm; Gary Hoffman; Ronald H Laessig; Philip M Farrell
Journal:  J Pediatr       Date:  2003-06       Impact factor: 4.406

4.  International perspectives on newborn screening.

Authors:  R J Pollitt
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

5.  Cost-effectiveness of 4 neonatal screening strategies for cystic fibrosis.

Authors:  M Elske van den Akker-van Marle; Hinke M Dankert; Paul H Verkerk; Jeannette E Dankert-Roelse
Journal:  Pediatrics       Date:  2006-09       Impact factor: 7.124

6.  Parental attitudes to the identification of their infants as carriers of cystic fibrosis by newborn screening.

Authors:  Sharon Lewis; Lisette Curnow; Margaret Ross; John Massie
Journal:  J Paediatr Child Health       Date:  2006-09       Impact factor: 1.954

7.  Newborn screening for cystic fibrosis: parents' preferences regarding counseling at the time of infants' sweat test.

Authors:  Audrey Tluczek; Rebecca L Koscik; Peggy Modaff; Darci Pfeil; Michael J Rock; Philip M Farrell; Caroline Lifchez; Mary Ellen Freeman; William Gershan; Christina Zaleski; Bradley Sullivan
Journal:  J Genet Couns       Date:  2006-08       Impact factor: 2.537

8.  Screening for cystic fibrosis: the practice and the debate.

Authors:  James R Bonham; Melanie Downing; Ann Dalton
Journal:  Eur J Pediatr       Date:  2003-11-14       Impact factor: 3.183

9.  Comprehensive genetic analysis of the cystic fibrosis transmembrane conductance regulator from dried blood specimens--implications for newborn screening.

Authors:  Anja Kammesheidt; Martin Kharrazi; Steve Graham; Suzanne Young; Michelle Pearl; Charles Dunlop; Steven Keiles
Journal:  Genet Med       Date:  2006-09       Impact factor: 8.822

10.  Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel.

Authors:  Michael S Watson; Garry R Cutting; Robert J Desnick; Deborah A Driscoll; Katherine Klinger; Michael Mennuti; Glenn E Palomaki; Bradley W Popovich; Victoria M Pratt; Elizabeth M Rohlfs; Charles M Strom; C Sue Richards; David R Witt; Wayne W Grody
Journal:  Genet Med       Date:  2004 Sep-Oct       Impact factor: 8.822
View more
  13 in total

1.  A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis.

Authors:  Janelle Wells; Marjorie Rosenberg; Gary Hoffman; Michael Anstead; Philip M Farrell
Journal:  Pediatrics       Date:  2012-01-30       Impact factor: 7.124

2.  Hispanic Infants with cystic fibrosis show low CFTR mutation detection rates in the Illinois newborn screening program.

Authors:  Kimberly Danieli Watts; Benjamin Layne; Ann Harris; Susanna A McColley
Journal:  J Genet Couns       Date:  2012-02-04       Impact factor: 2.537

3.  Clinical and ethical considerations in managing carrier detection.

Authors:  Lainie Friedman Ross; Ellen Wright Clayton
Journal:  Am J Public Health       Date:  2009-06-18       Impact factor: 9.308

4.  Universal state newborn screening programs can reduce health disparities.

Authors:  Jeffrey P Brosco; Scott D Grosse; Lainie Friedman Ross
Journal:  JAMA Pediatr       Date:  2015-01       Impact factor: 16.193

5.  Initial evaluation of a biochemical cystic fibrosis newborn screening by sequential analysis of immunoreactive trypsinogen and pancreatitis-associated protein (IRT/PAP) as a strategy that does not involve DNA testing in a Northern European population.

Authors:  Olaf Sommerburg; Martin Lindner; Martina Muckenthaler; Dirk Kohlmueller; Svenja Leible; Reinhard Feneberg; Andreas E Kulozik; Marcus A Mall; Georg F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2010-08-17       Impact factor: 4.982

6.  Acute Recurrent and Chronic Pancreatitis as Initial Manifestations of Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator-Related Disorders.

Authors:  Christina Baldwin; Melissa Zerofsky; Meghana Sathe; David M Troendle; Emily R Perito
Journal:  Pancreas       Date:  2019-08       Impact factor: 3.327

7.  Changing incidence of cystic fibrosis in Wisconsin, USA.

Authors:  Katelyn Parker-McGill; Melodee Nugent; Rachel Bersie; Gary Hoffman; Michael Rock; Mei Baker; Philip M Farrell; Pippa Simpson; Hara Levy
Journal:  Pediatr Pulmonol       Date:  2015-08-10

8.  Screening for Regulatory Variants in 460 kb Encompassing the CFTR Locus in Cystic Fibrosis Patients.

Authors:  Jenny L Kerschner; Sujana Ghosh; Alekh Paranjapye; Wilmel R Cosme; Marie-Pierre Audrézet; Miyuki Nakakuki; Hiroshi Ishiguro; Claude Férec; Johanna Rommens; Ann Harris
Journal:  J Mol Diagn       Date:  2018-10-05       Impact factor: 5.568

9.  Prospective and parallel assessments of cystic fibrosis newborn screening protocols in the Czech Republic: IRT/DNA/IRT versus IRT/PAP and IRT/PAP/DNA.

Authors:  Veronika Krulišová; Miroslava Balaščaková; Veronika Skalická; Tereza Piskáčková; Andrea Holubová; Jana Paděrová; Petra Křenková; Lenka Dvořáková; Dana Zemková; Petr Kračmar; Blanka Chovancová; Věra Vávrová; Alexandra Stambergová; Felix Votava; Milan Macek
Journal:  Eur J Pediatr       Date:  2012-05-12       Impact factor: 3.183

Review 10.  Cystic Fibrosis.

Authors:  Kimberly M Dickinson; Joseph M Collaco
Journal:  Pediatr Rev       Date:  2021-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.